Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide with or without spacer in asthma
NCT00163436Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2005
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 3, randomised trial of ciclesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in 1 second. Started Sep 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00163436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163436.